Literature DB >> 16259885

Comparison of bariatric and non-bariatric elective operations in morbidly obese patients on the basis of wound infection.

Serdar Topaloglu1, Fatih M Avsar, Hakan Ozel, Merve Babacan, Huseyin Berkem, Yigit Yildiz, Suleyman Hengirmen.   

Abstract

BACKGROUND: Wound infection rates after various types of bariatric operations have been well described. The question of whether bariatric surgery increases wound infection rate compared with similar elective surgical procedures in obese patients has not been clearly answered. The purpose of this study was to investigate wound status of morbidly obese patients after elective general surgery.
METHODS: A prospective evaluation was conducted of 141 morbidly obese patients undergoing bariatric (n=60) and non-bariatric elective general surgery operation of similar invasiveness (n=81) with the ASEPSIS wound surveillance method.
RESULTS: Median age of patients undergoing non-bariatric elective surgery (51, 32-68) was significantly higher than patients exposed to bariatric surgery (39, 24-57). Patients undergoing bariatric surgery had higher BMIs (44.0, 35-52.5) compared to the others (38.4, 35-43). All patients enrolled in the study were followed for a 21-day period. At the 7th postoperative day, 9 patients in the bariatric surgery group developed infection (15%), whereas 13 patients (16%) in the non-bariatric surgery group suffered wound infection. Wound infection was still present in 2 patients (3.4%) in the bariatric surgery group and 3 patients (3.7%) in the non-bariatric surgery group at the 21st day. Risk factors for wound infection included history of coronary artery diseases, diabetes, chronic respiratory illness and malignant disease.
CONCLUSION: Bariatric surgery does not cause an additional risk of postoperative wound infection in morbidly obese patients, compared to elective general surgical operations of the same invasiveness.

Entities:  

Mesh:

Year:  2005        PMID: 16259885     DOI: 10.1381/096089205774512465

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  6 in total

1.  Cefepime dosing in the morbidly obese patient population.

Authors:  Barrie S Rich; Rebecca Keel; Vanessa P Ho; Harma Turbendian; Cheguevara I Afaneh; Gregory F Dakin; Alfons Pomp; David P Nicolau; Philip S Barie
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

Review 2.  Preventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.

Authors:  Teena Chopra; Jing J Zhao; George Alangaden; Michael H Wood; Keith S Kaye
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

3.  Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.

Authors:  Rochelle L Ryan; Dwane Jackson; George Hopkins; Victoria Eley; Rebecca Christensen; Andre A J Van Zundert; Steven C Wallis; Jeffrey Lipman; Suzanne L Parker; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2022-06-28       Impact factor: 5.938

4.  Serum in vivo and in vitro activity of single dose of ertapenem in surgical obese patients for prevention of SSIs.

Authors:  Carlo de Werra; Rosa Di Micco; Vincenzo Pilone; Antonio Formato; Emma Montella; Antonietta Lambiase; Domenica Cerbone; Maria Rosaria Catania; Pietro Forestieri
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

5.  Efficacious Cefazolin Prophylactic Dose for Morbidly Obese Women Undergoing Bariatric Surgery Based on Evidence from Subcutaneous Microdialysis and Populational Pharmacokinetic Modeling.

Authors:  Eduardo Celia Palma; Nelson Guardiola Meinhardt; Airton Tetelbom Stein; Isabela Heineck; Maria Isabel Fischer; BibianaVerlindo de Araújo; Teresa Dalla Costa
Journal:  Pharm Res       Date:  2018-04-11       Impact factor: 4.200

6.  The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients.

Authors:  Glenn S Gerhard; Ravi Chokshi; Christopher D Still; Peter Benotti; G Craig Wood; Mollie Freedman-Weiss; Cody Rider; Anthony T Petrick
Journal:  Patient Saf Surg       Date:  2011-01-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.